Similar articles for PMID: 15274365

Year	Number of Results
1994	1
1995	2
1997	1
1998	2
1999	3
2000	4
2001	3
2002	4
2003	20
2004	21
2005	23
2006	40
2007	26
2008	27
2009	32
2010	26
2011	29
2012	33
2013	40
2014	24
2015	25
2016	22
2017	13
2018	12
2019	15
2020	8
2021	12
2022	2
2023	3
2024	1

1

Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer.

Yoshida K, Hirabayashi N, Takiyama W, Ninomiya M, Takakura N, Sakamoto J, Nishiyama M, Toge T. Yoshida K, et al. Anticancer Res. 2004 May-Jun;24(3b):1843-51. Anticancer Res. 2004. PMID: 15274365 Free article. Clinical Trial.

2

A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.

Rino Y, Takanashi Y, Yukawa N, Saeki H, Wada H, Kanari M, Yamada R, Satoh T, Yamamoto N, Imada T. Rino Y, et al. Anticancer Res. 2006 Mar-Apr;26(2B):1455-62. Anticancer Res. 2006. PMID: 16619558 Free article. Clinical Trial.

3

Phase I study of combination therapy with S-1 and weekly docetaxel for advanced gastric cancer.

Ozaki T, Tamura K, Satoh T, Kurata T, Shimizu T, Miyazaki M, Okamoto I, Nakagawa K, Fukuoka M. Ozaki T, et al. Anticancer Res. 2007 Jul-Aug;27(4C):2657-65. Anticancer Res. 2007. PMID: 17695429 Free article. Clinical Trial.

4

Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer.

Takahashi I, Emi Y, Kakeji Y, Tokunaga E, Ushiro S, Oki E, Watanabe M, Baba H, Maehara Y. Takahashi I, et al. Oncol Rep. 2006 Apr;15(4):849-54. Oncol Rep. 2006. PMID: 16525670 Clinical Trial.

5

Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.

Yoshida K, Ninomiya M, Takakura N, Hirabayashi N, Takiyama W, Sato Y, Todo S, Terashima M, Gotoh M, Sakamoto J, Nishiyama M. Yoshida K, et al. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3402-7. doi: 10.1158/1078-0432.CCR-05-2425. Clin Cancer Res. 2006. PMID: 16740764 Clinical Trial.

6

Phase I study of a combination of s-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.

Ueda Y, Yamagishi H, Ichikawa D, Morii J, Koizumi K, Kakihara N, Shimotsuma M, Takenaka A, Yamashita T, Kurioka H, Nishiyama M, Morita S, Nakamura K, Sakamoto J. Ueda Y, et al. Oncology. 2005;69(3):261-8. doi: 10.1159/000088072. Epub 2005 Sep 1. Oncology. 2005. PMID: 16138002 Clinical Trial.

7

Phase I study of biweekly docetaxel and S-1 combination chemotherapy for advanced gastric cancer.

Kunisaki C, Takahashi M, Nagahori Y, Makino H, Takagawa R, Sato T, Oshima T, Fujii S, Kosaka T, Ono HA, Akiyama H, Shimada H. Kunisaki C, et al. Anticancer Res. 2008 Jul-Aug;28(4C):2473-8. Anticancer Res. 2008. PMID: 18751437 Free article. Clinical Trial.

8

[Combination chemotherapy of TS-1 and docetaxel on advanced and recurrent gastric cancer].

Yoshida K, Toge T. Yoshida K, et al. Gan To Kagaku Ryoho. 2004 Nov;31(12):1982-6. Gan To Kagaku Ryoho. 2004. PMID: 15570925 Review. Japanese.

9

Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer.

Kim YH, Seo HY, Jeen YT, Kim HK, Shim BY, Yang J. Kim YH, et al. Cancer Chemother Pharmacol. 2009 Jan;63(2):253-60. doi: 10.1007/s00280-008-0734-6. Epub 2008 May 21. Cancer Chemother Pharmacol. 2009. PMID: 18493761 Clinical Trial.

10

Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.

Cui Y, Li Q, Yu Y, Chen Y, Feng Y, Wang Y, Liu T. Cui Y, et al. Cancer Chemother Pharmacol. 2013 Jan;71(1):145-52. doi: 10.1007/s00280-012-1991-y. Epub 2012 Oct 12. Cancer Chemother Pharmacol. 2013. PMID: 23064955 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

405 results

Results by year